ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ARTHD Arch Therapeutics Inc (QB)

3.60
0.00 (0.00%)
Apr 11 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0.00
Bid Price
Ask Price
News -
Share Name Share Symbol Market Stock Type
Arch Therapeutics Inc (QB) ARTHD OTCMarkets Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 3.60 19:00:00
Open Price Low Price High Price Close Price Previous Close
3.60 3.60
Trades Shares Traded Average Volume
0 0.00 -
Last Trade Type Quantity Price Currency
- 0 US$ 3.60 USD

Arch Therapeutics Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
US$ 4.63M 1.29M 1.02M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Arch Therapeutics (QB) News

Date Time Source News Article
4/03/202416:07Edgar (US Regulatory)Form 8-K - Current report
3/18/202415:29Edgar (US Regulatory)Form 8-K - Current report
3/01/202415:31Edgar (US Regulatory)Form 8-K - Current report
3/01/202415:30Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
2/20/202416:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/15/202415:30Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form..
2/07/202415:30Edgar (US Regulatory)Form 8-K - Current report
1/22/202411:39Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
1/12/202415:30Edgar (US Regulatory)Form 8-K - Current report
1/11/202415:30Edgar (US Regulatory)Form 8-K - Current report
12/29/202315:30Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form..
12/15/202315:31Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ARTHD Message Board. Create One! See More Posts on ARTHD Message Board See More Message Board Posts

Historical ARTHD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years5.967.003.014.901,957-2.36-39.60%
5 Years5.967.003.014.901,957-2.36-39.60%

Arch Therapeutics (QB) Description

Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch's products authorized for commercial marketing are AC5 Advanced Wound System and AC5 Topical Hemostat. Arch's development stage product candidates include AC5-GTM and AC5 Surgical Hemostat, among others.

Your Recent History

Delayed Upgrade Clock